C12N 2770/32011
Picornaviridae
C12N2770/32011 (Picornaviridae) appears on 714 US grants and 857 published applications in this corpus.
Search patents in C12N- Granted patents
- 714
- Published applications
- 857
- Assignees
- 477
- Inventors
- 2,000
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 7 | 0 |
| 1978 | 9 | 0 |
| 1979 | 2 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 5 | 0 |
| 1986 | 6 | 0 |
| 1987 | 5 | 0 |
| 1988 | 6 | 0 |
| 1989 | 3 | 0 |
| 1990 | 5 | 0 |
| 1991 | 4 | 0 |
| 1992 | 6 | 0 |
| 1993 | 9 | 0 |
| 1994 | 9 | 0 |
| 1995 | 7 | 0 |
| 1996 | 16 | 0 |
| 1997 | 16 | 0 |
| 1998 | 16 | 0 |
| 1999 | 17 | 0 |
| 2000 | 35 | 0 |
| 2001 | 15 | 4 |
| 2002 | 14 | 16 |
| 2003 | 11 | 46 |
| 2004 | 17 | 27 |
| 2005 | 13 | 25 |
| 2006 | 10 | 27 |
| 2007 | 13 | 17 |
| 2008 | 10 | 23 |
| 2009 | 9 | 25 |
| 2010 | 13 | 39 |
| 2011 | 17 | 28 |
| 2012 | 16 | 35 |
| 2013 | 16 | 32 |
| 2014 | 27 | 36 |
| 2015 | 15 | 41 |
| 2016 | 30 | 37 |
| 2017 | 25 | 40 |
| 2018 | 38 | 45 |
| 2019 | 49 | 56 |
| 2020 | 32 | 46 |
| 2021 | 31 | 41 |
| 2022 | 28 | 44 |
| 2023 | 19 | 33 |
| 2024 | 25 | 47 |
| 2025 | 23 | 29 |
| 2026 | 7 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2770/32611PoliovirusIndexing code241
- C12N 2770/32111AphthovirusIndexing code159
- C12N 2770/32411Hepatovirus, i.e. hepatitis a virusIndexing code129
- C12N 2770/32311EnterovirusIndexing code124
- C12N 2770/32711RhinovirusIndexing code65
- C12N 2770/32022New viral proteins or individual genes, new structural or functional aspects ofIndexing code37
- C12N 2770/32034Use of virus or viral component as vaccineIndexing code37
- C12N 2770/32051Methods of production or purification of viral materialIndexing code24
All 19 subgroupsShow fewer
- C12N 2770/32021Viruses as suchIndexing code18
- C12N 2770/32023Virus like particles [vlp]Indexing code15
- C12N 2770/32211CardiovirusIndexing code15
- C12N 2770/32061Methods of inactivation or attenuationIndexing code14
- C12N 2770/32033Use of viral protein as therapeutic agent other than vaccineIndexing code9
- C12N 2770/32041Use of virus, viral particle or viral elements as a vectorIndexing code9
- C12N 2770/32032Use of virus as therapeutic agent, other than vaccineIndexing code7
- C12N 2770/32071Demonstrated in vivo effectIndexing code7
- C12N 2770/32031Uses of virus other than therapeutic or vaccineIndexing code4
- C12N 2770/32511ParechovirusIndexing code1
- C12N 2770/32088For redistributionIndexing code0
Recent patents
- Constructs and methods for preparing circular RNA23 Jun 2026US 12,662,671 B2Peking University
- Click outer membrane vesicles16 Jun 2026US 12,653,882 B2Intravacc B.V.
- Micromolded or 3-D printed pulsatile release vaccine formulations12 May 2026US 12,622,963 B2Massachusetts Institute of Technology
- Foot-and-mouth disease virus-like particle antigen, vaccine composition, preparation method, and use thereof28 Apr 2026US 12,611,452 B2Pulike Biological Engineering, Inc.
- Hepatitis A virus preparation method and hepatitis A virus prepared according to method24 Feb 2026US 12,558,417 B2SK Bioscience Co., Ltd.
- Differential coating of microprojections and microneedles on arrays8 Oct 2026US 2026/0306611 A1Vaxxas Pty Limited
- Artificial secoviridae satellite rnas1 Oct 2026US 2026/0297596 A1Flagship Pioneering Innovations Vii, LLC
- Intracellular Delivery of Therapeutic Cargos and Viral RNAS by Engineered Salmonella17 Sep 2026US 2026/0272995 A1The Trustees of Columbia University in the City of New York
- Rna vectors with hairpin-like inserts17 Sep 2026US 2026/0275366 A1
- Compositions and methods for improved protein translation from recombinant circular rnas13 Aug 2026US 2026/0234654 A1The Board of Trustees of the Leland Stanford Junior University
Most cited
By later US patents
- Method for processing and preserving collagen-based tissues for transplantation610US 5,336,616 ALifeCell Corporation · 1994
- Composition for introducing nucleic acid complexes into higher eucaryotic cells257US 5,547,932 ABoehringer Ingelheim International GmbH · 1996
- Multiple pharmaceutical dispenser with accumulator207US 5,298,023 AHabley Medical Technology Corporation · 1994
- Antigenically active amino acid sequences190US 4,708,871 ACommonwealth Serum Laboratories Commission · 1987
- Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes185US 5,316,931 ABiosource Genetics Corporation · 1994